Editorial comment
Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: Should we keep doing it?
Dose de carga de inibidor P2Y12 o mais cedo possível no contexto de enfarte agudo do miocárdio com supradesnivelamento do segmento ST: fazer ou não fazer, eis a questão
Gonçalo Proença
Assistente Graduado Cardiologia, Coordenador Unidade de Cardiologia Hospital de Cascais, Portugal
Read
3218
Timeswas read the article
1491
Total PDF
1727
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 3 | 11 |
| 2025 5 | 65 | 29 | 94 |
| 2025 4 | 61 | 35 | 96 |
| 2025 3 | 77 | 26 | 103 |
| 2025 2 | 44 | 22 | 66 |
| 2025 1 | 47 | 39 | 86 |
| 2024 12 | 40 | 25 | 65 |
| 2024 11 | 50 | 32 | 82 |
| 2024 10 | 31 | 33 | 64 |
| 2024 9 | 46 | 30 | 76 |
| 2024 8 | 44 | 33 | 77 |
| 2024 7 | 58 | 32 | 90 |
| 2024 6 | 31 | 30 | 61 |
| 2024 5 | 35 | 21 | 56 |
| 2024 4 | 43 | 31 | 74 |
| 2024 3 | 33 | 18 | 51 |
| 2024 2 | 28 | 26 | 54 |
| 2024 1 | 27 | 20 | 47 |
| 2023 12 | 27 | 25 | 52 |
| 2023 11 | 20 | 30 | 50 |
| 2023 10 | 17 | 15 | 32 |
| 2023 9 | 23 | 20 | 43 |
| 2023 8 | 19 | 21 | 40 |
| 2023 7 | 22 | 6 | 28 |
| 2023 6 | 23 | 17 | 40 |
| 2023 5 | 32 | 26 | 58 |
| 2023 4 | 16 | 9 | 25 |
| 2023 3 | 29 | 25 | 54 |
| 2023 2 | 27 | 20 | 47 |
| 2023 1 | 22 | 13 | 35 |
| 2022 12 | 41 | 19 | 60 |
| 2022 11 | 32 | 24 | 56 |
| 2022 10 | 27 | 29 | 56 |
| 2022 9 | 17 | 42 | 59 |
| 2022 8 | 22 | 27 | 49 |
| 2022 7 | 23 | 44 | 67 |
| 2022 6 | 19 | 29 | 48 |
| 2022 5 | 27 | 32 | 59 |
| 2022 4 | 24 | 37 | 61 |
| 2022 3 | 25 | 43 | 68 |
| 2022 2 | 32 | 40 | 72 |
| 2022 1 | 18 | 29 | 47 |
| 2021 12 | 26 | 36 | 62 |
| 2021 11 | 24 | 49 | 73 |
| 2021 10 | 29 | 46 | 75 |
| 2021 9 | 21 | 35 | 56 |
| 2021 8 | 22 | 33 | 55 |
| 2021 7 | 12 | 23 | 35 |
| 2021 6 | 24 | 20 | 44 |
| 2021 5 | 25 | 44 | 69 |
| 2021 4 | 77 | 48 | 125 |
| 2021 3 | 44 | 20 | 64 |
| 2021 2 | 35 | 8 | 43 |
| 2021 1 | 29 | 17 | 46 |
| 2020 12 | 7 | 5 | 12 |
Show all
